October 2012 Volume 8, Issue 10

Volume 8, Issue 10 | October 2012

October 2012

In this Issue

Global News

Drug Discovery News Placeholder Image

Company complements are more than skin deep

Valeant acquires Medicis for $2.6 billion
Drug Discovery News Placeholder Image

Adding mixtures to the mix

Merck, Symphogen ink $600 million-plus licensing deal for recombinant antibody for oncology
Drug Discovery News Placeholder Image

Going through a phage

AmpliPhi to acquire Special Phage Services to create anti-infective company focused on bacteriophage-based therapies
Drug Discovery News Placeholder Image

Mad about mAbs

Genmab licenses monoclonal antibody cancer treatment to Janssen Biotech in deal worth more than $1.1 billion
Drug Discovery News Placeholder Image

Give them a C

Medivir acquires preclinical antiviral programs from Novadex, including hepatitis C and prodrug technologies

Research & Development

Drug Discovery News Placeholder Image

Court upholds federal hESC research funding

Plaintiff’s arguments in contentious Sherley v. Sebelius case rejected
Drug Discovery News Placeholder Image

Acquisition elevates Sunovion’s respiratory focus

Company’s $100 million-plus purchase of Elevation Pharmaceuticals comes with novel nebulizer for COPD
Drug Discovery News Placeholder Image

Marching toward the front line

SFJ and Pfizer to co-develop dacomitinib as first-line treatment for patients with advanced non-small cell lung cancer
Drug Discovery News Placeholder Image

Fixing broken hearts

University of Maryland cardiac studies explore use of stem cells to reduce ripple effect, help children
Drug Discovery News Placeholder Image

A window into VISTA

Partnership aims to develop immunotherapies for cancer based on new negative checkpoint regulator

Omics & Systems Biology

Drug Discovery News Placeholder Image

Treasure in the junk

ENCODE project finds much less garbage in what has been called ‘junk DNA’
Drug Discovery News Placeholder Image

An infectious attitude

AstraZeneca, Broad Institute announce antibacterial, antiviral collaboration
Drug Discovery News Placeholder Image

Three partners, one target

Two British research organizations team with California-based pharma company to discover and develop novel blood cancer drug candidates
Drug Discovery News Placeholder Image

An alternative to liver transplantation

Collaboration between University of Cambridge and GSK seeks a breakthrough in A1AT deficiency treatment
Drug Discovery News Placeholder Image

Collaborators seek MS biomarkers

Biogen Idec and Regulus Therapeutics to look for microRNAs as biomarkers for multiple sclerosis

Diagnostics

Drug Discovery News Placeholder Image

Intel inside Ivy

Stanford uses Intel chip to analyze protein interactions, diagnose disease
Drug Discovery News Placeholder Image

Paradigm for personalized medicine

U-M/IGC joint venture uses genetic information to understand and treat disease
Drug Discovery News Placeholder Image

A picture-perfect focus

MacroGenics, ImaginAb collaboration to develop clinical imaging agents
Drug Discovery News Placeholder Image

Partners target ovarian cancer

Toronto biotech Axela and Calif.-based OvaGene Oncology develop molecular diagnostics test
Drug Discovery News Placeholder Image

PathGEN inks pact with Affymetrix

Companies to tackle diagnostic test development for pathogen detection

Commentary

Drug Discovery News Placeholder Image

Barcodes in drug discovery: The quiet revolution

From the grocery store to the microwell plate in your lab, barcodes are ever-present. But our knowledge of them is often superficial, and as a result, we don’t fully enjoy their benefits. Their critical role in drug discovery suggests knowing how they work makes us more productive users of the technology.
Drug Discovery News Placeholder Image

Who needs R&D tax credits?

No one with a brain makes an R&D decision based on tax credits. We make those decisions to try for a competitive advantage. If we don’t achieve that advantage, we shouldn’t expect to be partially reimbursed for the effort just to have our butts protected in a plea for fairness.

Editor's Focus

Drug Discovery News Placeholder Image

When the medium isn’t the message anymore

“Quotation approval” might have come into practice because sources wanted to ensure that their statements are correct and properly attributed, but unfortunately, this process often goes far beyond making sure a journalist recorded your statements accurately.

Special Reports

Drug Discovery News Placeholder Image

A companion in your corner (Part 1)

CDx market sees strong growth despite regulatory, development burdens
Drug Discovery News Placeholder Image

A companion in your corner (Part 2)

CDx market sees strong growth despite regulatory, development burdens

Contract Services

Drug Discovery News Placeholder Image

Charles River acquires Accugenix

CRO expands microbial identification capabilities
Drug Discovery News Placeholder Image

QPS acquires JSW Life Sciences, Austria’s largest independent CRO

CROs look to expand global footprint, particularly among CNS clients
Drug Discovery News Placeholder Image

A venture in the East

MedImmune, WuXi AppTec announce joint venture to commercialize in China
Drug Discovery News Placeholder Image

From Ireland with love

ICON partners with University College Dublin to advance genetic analysis and clinical research

Feature

Drug Discovery News Placeholder Image

Being human: ASHG 2012 annual meeting preview

American Society for Human Genetics delves into specifics of human genome in San Francisco

Tools & Technology

Drug Discovery News Placeholder Image

Filling a ‘critical’ gap

Agilent now offers single-vendor solutions in supercritical fluid chromatography with acquisition of Aurora SFC Systems’ assets
Drug Discovery News Placeholder Image

Leica Biosystems acquires Aperio

Aperio’s ePathology solutions key to the deal
Drug Discovery News Placeholder Image

Seeking growth with Molegro

CLC bio acquires Molegro, expands bioinformatics offering
Drug Discovery News Placeholder Image

No gene left behind

PerkinElmer and Massachusetts General Hospital to develop a complete sequencing informatics system for cancer research
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue